Investorideas.com newswire, breaking news for marijuana, cannabis and hemp stocks

Monday, 11 May 2020

#Cannabis News: Cannabis Suisse (OTC: $CSUI) Launches Pre-Rolled Cannabis Joints Based on the V1 Cannabis Strain; @SuisseCorp


#Cannabis News: Cannabis Suisse (OTC: $CSUI) Launches Pre-Rolled Cannabis Joints Based on the V1 Cannabis Strain; @SuisseCorp


Dietikon, Switzerland - May 11, 2020 (Investorideas.com Newswire) For the purpose of standing out, Cannabis Suisse Corp. (OTC: CSUI) has announced a new retail product in the variety of the Company's offerings. They range from helping consumers grow their own Cannabis plants to a revolutionary pure base CBD vape liquid. During the global crisis the Company is not ceasing to create and deliver innovative ideas.


Since the cannabis industry has developed, the brands on the market have been working extensively on improving the production quantity and the quality of pre-rolled joints. They have become so popular among users of recreational cannabis due to their small size and compactness.

It's a rather easy-to-use product that delivers an enjoyable and unique experience anytime people use it.

The consistency of the joints is simply royal which is no surprise due to Cannabis Suisse Corp. getting permission to use RAW brand on their pre-rolled boxes. RAW is known for their best of the best rolling papers. They come unbleached, contain neither chalk, nor dyes, nor flammable additives. These papers just immerse smokers into the experience of using the finest strains of V1 cannabis. Wrapped in unrefined natural paper, the joints give customers a unique smoking experience with a gourmet taste.

The V1 is special for its ability to relax users without sedation and to relieve them without intoxication. It is not new, however, appears to be the best strain on the market currently. The V1 strain is an immensely powerful CBD plant and is guaranteed to contain not less than 20% CBD along with no more than 0.85% THC. It is delicious to smoke having a natural hint of lemon and lime flavors and an enjoyable fresh aftertaste.

The V1 strains are derived from recreational strains and are one of the best-selling products on the market. Over the last few years, the V1 has surely become one of the most exciting CBD strains containing around 90% Sativa and 10% Indica. The V1 plant is known to have low yield however it is widely used for therapeutic purposes. People who tried consuming it in different ways report having a feeling of peace and relaxation. It is easy to recognize by hard compact flowerheads. Apart from the crystal appearance, the V1 also has a strong specific scent.

V1 will be the main strain for ALPINE CANNABIS CBD tobacco production.

Cannabis users from California, Colorado, Arizona, Oregon, and Washington spent around $36 million in pre-rolled joints only in May of 2019 according to the report introduced by BDS Analytics. (https://bdsa.com/wp-content/uploads/2019/07/CPI-Template-May.pdf) Apart from that, at the end of 2019, the Swiss government finally removed the 25% tobacco tax which was a significant event for the country. In five years from now, Europe is expected to become the largest legal cannabis market in the world. In 2019, the industry there has grown more than in the last six years together.

As always, CSUI's pre-rolled CBD joints are wrapped in premium quality paper from RAW. They will be made only of quality fresh buds (no leaves, of course) cultivated with non-pesticide fertilizers and biological control agents. The new product line of handmade pre-rolled CBD joints will have no additives. They are free from pesticides, fungicides, heavy metals or nicotine. Natural hemp is always manually harvested and selected with care. No post-harvest wash processing of the cannabis applies. The final product contains all the natural terroir it is supposed to have. This is the Cannabis Suisse finest ready-to-smoke weed product ever cultivated using proprietary growing methods in fully contained facilities in Zurich, Switzerland.

Cannabis Suisse is the first company in Switzerland to offer this uniquely blended fusion of organic cones with optimally boosted CBD content. The THC level has been naturally kept under 1%. CBD flower pre-rolled joints are an all-natural alternative to CBD oil products. They offer pain-relieving, calming, and anti-inflammatory properties.

Any cannabis consumer knows how difficult it is to choose a pre-rolled joint. There are lots of doubts whether a package has really as much cannabis flower as the manufacturer indicated, how joints will be wrapped and glued, how they will smolder. Alpine Cannabis buyers will never encounter such problems. The company maintains its work at a high-quality standard. The trademark gives consumers 100% confidence they will get premium quality goods. The quality of the pre-rolled joints is not going to be different from the quality of cannabis buds in bags where consumers can make sure what they are buying.
Moreover, upon trying and realizing the convenience of the joints, consumers will return for them over and over again.

Each step of the creation process is taken by masters. The Company is happy to present the highest quality and best priced CBD flower pre-rolled joints for the Swiss retail market. The V1 strain is currently growing and the first retail supplies of this product are expected to be ready for selected vendors in July 2020.

CSUI has forward-looking plans to expand outside Switzerland developing customized products. Some European countries like Germany, Denmark, Malta, Greece, and Italy discussed the possibility of creating a completely regulated cannabis market by 2028.
Furthermore, Luxembourg intends to introduce a regulated market for adult use of cannabis by 2023.

Based on all of the above advantages of the Company's product, the situation in the European market and forthcoming amendments to the legislation, the Company's decision to launch a new product line is more than an appropriate and timely one. An investment in this production will pay off for the company in the nearest future, increase the income, and make the brand recognizable. In our forecasts, to get a minimum of 400,000 CHF 12 months after the start of sales. CSUI's pre-rolled joints will become another business card of the Company's trademark. The product will occupy this niche in the market, crowding out other similar products.

ABOUT CANNABIS SUISSE CORP.
Cannabis Suisse Corp. is a fully licensed cannabis cultivation and distribution company in Switzerland, for recreational tobacco products and medical CBD oils. The Company's facilities for producing cannabis are based in Dietikon, Switzerland, and contain the art surveillance equipment to enable an around the clock webcast. Cannabis Suisse grows high quality, organic cannabis with sustainable, all-natural principles. The Company's products are laboratory tested to ensure the end users have access to a standardized, safe and consistent product. Cannabis Suisse proprietary trademarked MoldStandard is a quantitative microbiology method for analyzing yeast and mold counts in harvested cannabis plants. Cannabis Suisse proprietary trademarked CannaMec is a method for quantifying and removing residual solvents during packaging and storage of CBD products. Cannabis Suisse Corp. currently sells via a distribution network of Swiss retailers and online shops, under the retail brand Alpine Cannabis.

FORWARD-LOOKING DISCLAIMER
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Cannabis Suisse Corp. to be materially different from the statements made herein.

Cannabis Suisse Corp.
Alain Parrik
alain@cannabissuisse.com

Cannabis Suisse is a featured stock on Investorideas.com

More info on CSUI at Investorideas.com Visit: https://www.investorideas.com/CO/CSUI/


Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
Disclosure : Cannabis Suisse Corp. (OTC: CSUI) is a paid monthly cannabis company on Investorideas.com ( five thousand per month) More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.


Get more Cannabis Stock Investor Ideas - news, articles, podcasts and stock directories







Friday, 8 May 2020

Investorideas.com - Cannabis Stock News: Aphria (TSX: $APHA.TO) (NYSE: $APHA) strengthens balance sheet with negotiated debt reduction

Investorideas.com - Cannabis Stock News: Aphria (TSX: $APHA.TO) (NYSE: $APHA) strengthens balance sheet with negotiated debt reduction

Investorideas.com - Cannabis Stock News: Supreme Cannabis (TSX: $FIRE) (OTCQX: $SPRWF) Third Quarter Earnings Release Scheduled for May 15, 2020

Investorideas.com - Cannabis Stock News: Supreme Cannabis (TSX: $FIRE) (OTCQX: $SPRWF) Third Quarter Earnings Release Scheduled for May 15, 2020

Get the latest Cannabis and Hemp stock news from www.investorideas.com

Investor Ideas #Potcasts Episode 411- #Cannabis News and #Stocks on the Move– (OTC: $CSUI) (NASDAQ: $CRON) (TSX: $CRON.TO) (TSXV: $KHRN.V) (CSE: $TRUL.C) (CSE: $INDS.C) (CSE: $JUSH.C)




Investor Ideas #Potcasts Episode 411- #Cannabis News and #Stocks on the Move– (OTC: $CSUI) (NASDAQ: $CRON) (TSX: $CRON.TO) (TSXV: $KHRN.V) (CSE: $TRUL.C) (CSE: $INDS.C) (CSE: $JUSH.C)

Delta, Kelowna, BC, May 8, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s podcast edition of  cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:




Today’s podcast overview/transcript:

Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

Today’s podcast is sponsored by Cannabis Suisse Corp. (OTC: CSUI), a research & development company licensed under Swiss Cannabis and tobacco regulations to cultivate and sell cannabis. The Company's facilities for producing cannabis are based in Zurich.

The Company grows high quality, organic cannabis with sustainable, all-natural principles. Cannabis Suisse products are laboratory tested to ensure the end users have access to a standardized, safe and consistent product.

In today’s podcast we will be looking at a few public company announcements.

But first, in recent news, “top officials at the independent agency that oversees the Massachusetts marijuana industry say they’re confident they can safely reopen recreational pot stores if Governor Charlie Baker reverses his emergency order forcing the businesses to close amid the coronavirus pandemic.”
Cannabis Control Commission chairman Steve Hoffman told reporters after the agency’s monthly meeting Thursday that he believes Massachusetts marijuana shops can operate safely by employing curbside pickup, appointment-only shopping, and other similar measures adopted by retailers that have remained open (including medical marijuana dispensaries overseen by the commission).
Hoffman said he “wants it known” that the commission is prepared to monitor the facilities and enforce state rules, including around social distancing, should they reopen. And in his strongest comments yet on the controversial cannabis shutdown, he noted that Massachusetts is the only state where marijuana is legal to have completely closed its recreational (or “adult-use”) industry. Marijuana firms are ineligible for federal bailouts, because the drug remains illegal under US law.
“It is unfair that Massachusetts adult-use operators are the only ones that are shut down across the country and are not eligible for any kind of federal assistance,” Hoffman told reporters during a virtual press conference. “I have no concerns whatsoever that we can operate this business safely. I think we’ve demonstrated that we can do so on the medical side of the business... [and] I think there’s absolutely no reason we can’t do exactly the same thing on the adult-use side.”

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) today announced its 2020 first quarter business results.
“Cronos Group started 2020 energized and determined to continue to see through our core strategic initiatives to drive long-term and sustainable growth. This quarter, we moved closer to officially entering the Israeli medical cannabis market with our Cronos Israel operations preparing to sell PEACE NATURALS™ branded dried flower products to medical patients. The Israeli medical market is a growing channel, and we look forward to serving this market in 2020 and beyond,” said Mike Gorenstein, CEO of Cronos Group.
“Despite the challenges and uncertainty posed by the COVID-19 pandemic, we remain agile and focused as a business. Our brand portfolio continues to launch innovative products to consumers as we adapt to an online-first distribution model in both the U.S. and Canada. We continue to reach our stakeholders and consumers through creative digital marketing. And our product innovation and R&D projects continue to progress. We believe the mission of our Company, to improve lives through cannabinoid innovation, resonates especially well during these times. We remain well-positioned and committed to generating sustainable, long-term value for shareholders and are confident 2020 will be a successful building year for Cronos Group.”
Some of the First Quarter 2020 Highlights included:
     Net revenue of $8.4 million in Q1 2020 increased by $5.4 million from Q1 2019. The increase year-over-year was primarily driven by continued growth in the adult-use Canadian cannabis market, sales resulting from the launch of cannabis vaporizers to the Canadian market, including both adult-use and direct-to-consumer, and the inclusion of the Redwood acquisition in our financial results.
     Gross profit (loss) of $(6.5) million in Q1 2020 decreased by $8.0 million from Q1 2019. The decrease year-over-year was primarily driven by an inventory write-down of $8.0 million on dried cannabis and cannabis extracts, as well as an increase in the marginal production cost at our Peace Naturals Campus, as we continue working towards operating at full capacity after the repurposing of the facility in the fourth quarter of 2019.
     The Company incurred an inventory write-down of $8.0 million, on dried cannabis and cannabis extracts, primarily driven by fixed-price contracts negotiated prior to cannabis product price compression due to broader trends of oversupply in the Canadian market. If we were to adjust for the effects of the inventory write-downs, gross profit in Q1 2020, would have been $1.5 million, representing a gross margin of 18%. We anticipate further inventory write-downs in the short-term due to pricing pressures in the marketplace and the impact of the Company's operational repurposing of the Peace Naturals Campus.
     Reported operating loss of $45.1 million in Q1 2020 increased by $34.9 million from Q1 2019. The reduction year-over-year was primarily driven by an increase in general and administrative expenses as a result of increased headcount, internal review costs of $4.4 million related to the restatement of our 2019 interim financial statements, higher sales and marketing costs related to brand development, and research and development costs related to our Ginkgo partnership, activities at Cronos Fermentation, and spending on vaporizer innovation at the Cronos Device Labs research and development center.

Khiron Life Sciences Corp. (TSXV: KHRN) (OTC: KHNRF)  announced that President Chris Naprawa will present live at Canaccord Genuity's 4th Annual Global Cannabis Virtual Conference on Tuesday, May 12, 2020 at 11:40am ET (8:40am PT).

Canaccord Genuity's Annual Global Cannabis Conference is an investor-focused virtual event that engages a global network of leading players in the cannabis industry. To join the presentation from Mr. Naprawa visit: http://wsw.com/webcast/canaccord39/khrn

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF), also announced that Chief Executive Officer Kim Rivers will present at the Canaccord Genuity's 4th Annual Cannabis Conference. The live presentation is scheduled for Tuesday, May 12, 2020, at 11 A.M. EST.

A webcast of Rivers' presentation will be available live on the "Investors Relations" section of Trulieve's website and can be accessed here: http://wsw.com/webcast/canaccord39/tcnnf. A replay of the presentation will be posted on the Trulieve website following the event.

Indus Holdings Inc. (CSE: INDS) (OTCQX: INDXF), announced that Mark Ainsworth, Indus Co-Founder and Chief Executive Officer and George Allen, Indus Chairman of the Board and Founder of Geronimo Capital, will present via webcast at the Canaccord Genuity 4th Annual Cannabis Conference on Tuesday, May 12, 2020, at 2:40 p.m. EST. They will also be available for one-on-one virtual meetings throughout the day with investors.

This virtual presentation comes weeks after the company announced its US$15.1 million recapitalization financing, along with its fiscal year end 2019 financial and operational results, and preliminary first quarter 2020 highlights. Mr. Ainsworth and Mr. Allen will discuss the company’s top priorities, which involve finalizing its cultivation expansion, improving operational efficiency, and focusing on the most profitable parts of the business. The company will present its strategic plan and path to self-sustaining profitability, operational improvements underway and 2020 go-forward strategy.

The webcast of this presentation will be available at: http://wsw.com/webcast/canaccord39/ind

InMed Pharmaceuticals Inc. (TSX: IN) (OTCQX: IMLFF), a clinical-stage pharmaceutical company developing medications targeting diseases with high unmet medical need and leading the way in the clinical development of cannabinol (CBN), announced that Eric. A. Adams, President & CEO of InMed, will present a corporate overview as part of the upcoming virtual conference:
     Canaccord Genuity's 4th Annual Cannabis Conference on Tuesday, May 12th, 2020 at
 12:00 PM PST / 3:00 PM EST.
A webcast of the presentation will be available at: http://wsw.com/webcast/canaccord39/imlff as well as from the Investor page of the InMed website at https://investors.inmedpharma.com/.

Jushi Holdings Inc. (CSE: JUSH) (OTCQX: JUSHF), a globally focused, multi-state cannabis and hemp operator, announced that Erich Mauff, Co-Founder, Co-President and Director of Jushi, will present in Canaccord Genuity’s 4th Annual Global Cannabis Conference to be held virtually on Tuesday, May 12, 2020.

Mr. Mauff will present via live webcast at 8:40 a.m. Eastern Time in Track 2. The live presentation can be accessed at the following link: http://wsw.com/webcast/canaccord39/jushf



Once again, today’s podcast was sponsored by Cannabis Suisse Corp. (OTC: CSUI), a research & development company licensed under Swiss Cannabis and tobacco regulations to cultivate and sell cannabis. The Company's facilities for producing cannabis are based in Zurich.
The Company grows high quality, organic cannabis with sustainable, all-natural principles. Cannabis Suisse products are laboratory tested to ensure the end users have access to a standardized, safe and consistent product.
Investor ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment   

Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp


To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher, Spreaker,   YouTube via Spreaker,  iHeartradio and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. Disclosure: CSUI is a paid featured cannabis stock on Investorideas.com More disclaimer info:
https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy:

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.


Download our Mobile App for iPhone and Android 

Contact Investorideas.com
800 665 0411


  





Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory


New Telehealth/Telemedicine Stocks added to Investor Ideas Directories (NYSE: $ANTM) (NYSE: $CVS) (CSE: $BLR.C) (TSX: $WELL.TO)


New Telehealth/Telemedicine Stocks added to Investor Ideas Directories (NYSE: $ANTM) (NYSE: $CVS) (CSE: $BLR.C) (TSX: $WELL.TO)

Also new stocks in cannabis, gaming, sports and mining










Point Roberts WA, Delta BC, May 8, 2020 – (Investorideas.com Newswire) Investorideas.com, a global news source and leading investor resource announces its weekly roundup of stocks added to its global stock directories, including telehealth, cannabis, gaming, sports and mining.


A new section following stocks in the telehealth and telemedicine sector has been added to the biotech and tech stocks lists.  See the complete lists here:

The latest stocks in cannabis, gaming and sports and mining are all new CSE (Canadian Stock Exchange) listings.

New Stocks added to Telehealth on Biotech stocks directory and Tech stocks directory
Anthem Inc. (NYSE:ANTM) is a leading health benefits company dedicated to improving lives and communities, and making healthcare simpler. Through its affiliated companies, Anthem serves more than 108 million people, including more than 42 million within its family of health plans. We aim to be the most innovative, valuable and inclusive partner.  Anthem delivers doctor visits to your phone through its telemedicine platform called LiveHealth

Blackhawk Growth Corp. (CSE: BLR; Frankfurt: 0JJ; OTC: BLRZF) is an investment issuer looking to capitalize on market and industry trends that can create substantial value for its shareholders. We look for opportunities all over the globe where we can leverage our knowledge, expertise, and experience to deliver substantial growth for our companies and our investors. Talk to Doc is an online telemedicine clinic and wellness brand that helps patients connect with doctors through an easy to use platform. www.talktodoc.ca will look to work directly with medical clinics and their doctors, in a range of specialties, with the ability to serve thousands of patients across Canada, providing a true stay-at-home solution for medical treatment nationwide.

CVS Health (NYSE:CVS) At CVS Health, we share a clear purpose: helping people on their path to better health. Through our health services, plans and community pharmacists, we’re pioneering a bold new approach to total health. Making quality care more affordable, accessible, simple and seamless, to not only help people get well, but help them stay well in body, mind and spirit. CVS Health is piloting several different telehealth opportunities, including making telehealth physician care accessible through CVS Health digital properties. CVS Health will also explore enabling MinuteClinic providers to consult with telehealth physicians to expand the scope of care offered at MinuteClinic. In addition, MinuteClinic will continue to provide telehealth care to patients in CVS retail stores and will explore serving as a site for in-person exams to facilitate telehealth medical visits.

WELL Health Technologies Corp. (TSX:WELL.TO) (OTC:WLYYF) is a unique company that operates Primary Healthcare Facilities, is the third largest Electronic Medical Records (EMR) supplier in Canada and is a provider of telehealth services.  WELL owns and operates 21 medical clinics, provides digital EMR software and services to over 1500 medical clinics across Canada and is a majority owner of SleepWorks Medical.  WELL's overarching objective is to empower doctors to provide the best and most advanced care possible while leveraging the latest trends in digital health.  WELL is publicly traded on the Toronto Stock Exchange under the symbol "WELL-T".  WELL was recognized as a TSX Venture 50 Company in 2018, 2019 and 2020. 

UnitedHealth Group Incorporated (NYSE:UNH) is a diversified health care company dedicated to helping people live healthier lives and helping to make the health system work better for everyone. UnitedHealth Group offers a broad spectrum of products and services through two distinct platforms: UnitedHealthcare, which provides health care coverage and benefits services; and Optum, which provides information and technology-enabled health services. Optum, our Health Services platform, is a leading information and technology-enabled health services business dedicated to modernizing the system and improving the health of people and communities

Telus Health (TSX:T.TO)(NYSE:TU) together with its subsidiaries, provides a range of telecommunications products and services in Canada. It operates through Wireless and Wireline segments. Virtual Care Links: Akira by TELUS Health instantly connects employees and their family members to Canadian healthcare providers who can triage, diagnose, refer and provide prescriptions and medical advice related for a wide range of health concerns — whether employees are at home, at work or on vacation.  TELUS EMR Virtual Visit – an encrypted, EMR-integrated solution that enables virtual encounters by phone, text or video. Babylon by TELUS Health is a free app that allows you to receive virtual healthcare from your phone, without leaving the house.

Humana (NYSE:HUM) is committed to helping our millions of medical and specialty members achieve their best health. Our successful history in care delivery and health plan administration is helping us create a new kind of integrated care with the power to improve health and well-being and lower costs. Our efforts are leading to a better quality of life for people with Medicare, families, individuals, military service personnel, and communities at large. To accomplish that, we support physicians and other health care professionals as they work to deliver the right care in the right place for their patients, our members. Our range of clinical capabilities, resources and tools – such as in-home care, behavioral health, pharmacy services, data analytics and wellness solutions – combine to produce a simplified experience that makes health care easier to navigate and more effective.

Biotricity Inc. (OTCQB: BTCYis a modern medical technology company focused on delivering innovative, remote biometric monitoring solutions to the medical and consumer markets, including diagnostic and post-diagnostic solutions for chronic conditions and lifestyle improvement. Biotricity’s R&D continues to focus on the preventative healthcare market, with a vision of putting health management into the hands of the individual. The company aims to support the self-management of critical and chronic conditions with the use of innovative solutions to ease the growing burden on the healthcare system

Parallax Health Sciences, Inc. (OTC:PRLXis a leading-edge technology, outcome-driven telehealth company that allows for cost-effective remote diagnosis, treatment and monitoring of patients through proprietary platforms of integrated products and services. The Company's interoperable novel applications provide patients point-of-care testing and monitoring with information communicated via internet-based mobile phone applications that are agnostic as to operating system and are built on highly sophisticated data analytics. Information is retrieved real-time by physicians who are monitoring patients with chronic diseases or through biometric feedback for health-related behavior modification, and is automated for integration into electronic health records. The Company's products and offerings capitalize on the digital transformation in healthcare for improved patient compliance, diagnosis and treatment, and support healthcare system cost savings and efficiencies.

Protech Home Medical Corp. (TSXV:PTQ.V) provides in-home monitoring and disease management services including end-to-end respiratory solutions for patients in the United States healthcare market. It seeks to continue to expand its offerings to include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility and other chronic health conditions. The primary business objective of the Company is to create shareholder value by offering a broader range of services to patients in need of in-home monitoring and chronic disease management. The Company’s organic growth strategy is to increase annual revenue per patient by offering multiple services to the same patient, consolidating the patient’s services and making life easier for the patient.

New Stocks added to Cannabis stocks directory
New Leaf Ventures Inc. (CSE:NLV) provides consulting services, real property, intellectual property, equipment for lease and enhanced ancillary services to a licensed cannabis producer and processor.

New Stocks added to Mining stocks directory
Origen Resources Inc. (CSE:ORGN) is a Vancouver, B.C. based mineral exploration company focused on generating, exploring and developing base and precious metal projects

FansUnite Entertainment Inc. (CSE:FANS) is a Sports and Entertainment company, focusing on technology related to regulated and lawful online sports betting, casino and other related products. The principal business will be operating the FansUnite B2C Sportsbook and the McBookie website, offering online sports betting and casino to the UK market. FansUnite is also a provider of technology solutions, products and services in the global gaming and entertainment industries and looks to acquire technology platforms and assets with high-growth potential in new or developing markets.

The directories are not meant as recommendations but as a research tool to discover opportunities and trading ideas in a particular sector.

About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news and press releases, research and our own original financial content. We were one of the first retail investor sites to cover renewable energy and cleantech stocks at investorideas.com and our domain Renewableenergystocks.com. We were also one of the most well- known and cited defense stock sites, featuring our domain Homelanddefensestocks.com at its peak.
We follow the money for investors as sector sentiment shifts and technology disrupts. Our mission is to provide investor ideas with breaking news, resources, industry articles and interviews with leading experts.      

Learn about investing in stocks and sector trends with our news alerts, articles,  podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea's original branded content includes the following podcasts and columns: Crypto CornerPlay by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate ChangeExploring Mining and the AI Eye.

Public companies within the sectors we cover use our news and content services to tell their story to interested investors. Paid for content is disclosed.  

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Learn more about our news, PR and social media services at Investorideas.com

Follow us on Twitter https://twitter.com/Investorideas
Download our Mobile App for iPhone and Android  


Contact Investorideas.com
800 665 0411



Public Support for Legalization Remains Strong, Despite Narrow Shortcomings in Challenging State Elections

Public Support for Legalization Remains Strong, Despite Narrow Shortcomings in Challenging State Elections : Public Support for Legalization...